Manufactured under ISO 13485 quality management systems, thoroughly evaluated for biocompatibility, and ready for clinical deployment in Moscow hospitals.
Comprehensive biological risk management under ISO 10993 and ISO 14971 standards for titanium, PEEK, and stainless steel internal fixation systems.
Biocompatibility testing forms the cornerstone of medical device regulatory clearance, patient safety, and clinical durability. For orthopedic implants intended for permanent structural implantation (defined by ISO 10993-1 as long-term tissue/bone contact exceeding 30 days), material safety must be proven through rigorous physical, chemical, toxicological, and biological evaluations. As a primary manufacturer and global supplier supporting medical device importers and healthcare providers in Moscow, Ortix Medical maintains stringent quality controls throughout every step of production—from raw metallurgical forging to final cleanroom packaging.
Information Gain Insight: Modern orthopedic biocompatibility extends far beyond basic cytotoxicity. It encompasses extractable/leachable profiling (ISO 10993-18), fretting corrosion kinetics, bone-implant interfacial osseointegration dynamics, and mechanical fatigue resistance under prolonged cyclic loading.
Every bone screw, locking plate, intramedullary nail, spinal pedicle system, and interbody fusion cage engineered at our facilities undergoes structured risk assessment. Below is the biological evaluation matrix implemented for our medical-grade titanium alloy (Ti-6Al-4V ELI / TC4) and PEEK implant systems:
| Test Endpoint | Standard Ref. | Testing Methodology | Clinical Significance for Moscow Surgeons |
|---|---|---|---|
| Cytotoxicity | ISO 10993-5 | In vitro L929 MEM elution & direct contact assays | Ensures non-lethal cellular contact; prevents localized osteoblast necrosis at the bone interface. |
| Sensitization & Irritation | ISO 10993-10 | Murine Local Lymph Node Assay (LLNA) & Intracutaneous Reactivity | Eliminates risk of type IV hypersensitivity reactions in diverse patient populations. |
| Systemic Toxicity | ISO 10993-11 | Acute, subacute, and subchronic systemic toxicity evaluation | Guarantees that soluble ion release does not induce systemic organ toxicity over multi-year periods. |
| Genotoxicity & Mutagenicity | ISO 10993-3 | Bacterial Reverse Mutation (Ames) & Mouse Lymphoma Assays | Protects patient DNA integrity against chronic low-level metallic ion leaching. |
| Implantation Effects | ISO 10993-6 | Histopathological analysis of bone and muscle sites (12–52 weeks) | Validates direct osteoconduction, trabecular remodeling, and minimal fibrous encapsulation. |
| Chemical Characterization | ISO 10993-18 | GC-MS, LC-MS, and ICP-MS for extractable/leachable profiles | Quantifies inorganic trace elements and organic residue levels down to parts-per-billion (ppb). |
Optimizing mechanical bio-functionality and cellular attachment through 5-axis precision machining and advanced surface chemistry.
We source raw titanium exclusively from certified medical-grade suppliers conforming to ASTM F136 and ASTM F67 standards. Ti-6Al-4V Extra Low Interstitial (ELI) offers superior fracture toughness, high yield strength (>860 MPa), and an elastic modulus matching natural cortical bone far better than stainless steel, reducing stress shielding.
Surface micro-topography controls cellular differentiation. Our SLA (Sandblasted, Large-grit, Acid-etched) technology creates dual-scale roughness (micro-submicro) that enhances initial protein adsorption and accelerates osteoblast migration. Type II Anodization forms a protective passivation layer that boosts wear resistance and minimizes ion release.
For spinal interbody fusion cages, medical PEEK (Polyether ether ketone) provides radiolucency under intraoperative X-ray fluoroscopy, allowing clear CT/MRI evaluation of bone fusion. Our additive 3D titanium printing capabilities construct open trabecular lattices with 60–70% porosity, mimicking natural cancellous bone architecture.
Addressing the evolving clinical, regulatory, and supply chain dynamics across Moscow's leading traumatology and orthopedic institutes.
Moscow serves as the healthcare hub of Russia and the CIS region, home to premier institutions such as the N.N. Priorov National Medical Research Center of Traumatology and Orthopedics (CITO), S.P. Botkin Moscow City Clinical Hospital, N.V. Sklifosovsky Research Institute for Emergency Medicine, and the Burdenko Neurosurgery Institute. Traumatologists and spinal surgeons across these centers demand high-tier mechanical reliability, precise screw thread pitch matching, ergonomic instrumentation, and impeccable biocompatibility profiles.
Regulatory Alignment (Roszdravnadzor & GOST R): Ortix Medical provides complete toxicological testing reports, ISO 13485 quality certificates, material traceability dossiers, and technical documentation prepared for smooth registration with Roszdravnadzor (Federal Service for Surveillance in Healthcare) and Eurasian Economic Union (EAEU) medical device compliance.
A trusted manufacturing partner for global distributors, OEM brands, and hospital procurement groups.
Operating under an ISO 13485 certified quality management system and registered with the U.S. FDA. Every lot is accompanied by raw material mill certificates, dimensional inspection records, and biological safety dossiers.
Houses over 450 modern CNC machine tools, including 5-axis DMG MORI maching centers and Citizen sliding-head lathes, generating an annual capacity of over ~20,000 precision implant units per day.
Our dedicated R&D team works directly with clinical advisors to engineer custom OEM/ODM solutions, private label laser marking, bespoke instrument tray designs, and rapid product modifications.
Distributors can consolidate pedicle screws, locking plates, IM nails, fusion cages, and surgical instruments within small batch orders, drastically lowering inventory risk for emerging market distributors.
Every implant system is matched with ergonomic, color-coded, high-durability surgical instrument sets (taps, reamers, benders, screwdrivers) to guarantee flawless surgical workflow inside the operating room.
Proven export experience supplying distributors across Europe, Asia, Latin America, and Russia. We provide multilingual packaging, localized IFU manuals, and express shipping to Moscow logistics hubs.
Addressing regulatory compliance, biocompatibility certification, lead times, and OEM customization.
Our complete ISO 10993 biological evaluation packages—including cytotoxicity, systemic toxicity, sensitization, and chemical characterization (ISO 10993-18)—are conducted by accredited 17025 laboratories. These reports are fully formatted to meet Roszdravnadzor and EAEU technical file dossier submission criteria for medical device registration.
Standard catalog products are maintained in buffer inventory and can be dispatched within 7–14 business days. Bulk OEM orders or custom-machined implants follow a scheduled 30-to-45-day production cycle, delivered via air freight or express overland routes to Sheremetyevo (SVO) or Moscow Ring Road distribution hubs.
Yes. We offer turnkey OEM/ODM services, including custom laser etching of your brand logo and part numbers onto titanium surfaces, customized blister pouch seal packaging, box labeling, and Russian-language Instructions for Use (IFU) in strict accordance with local medical labeling standards.
We use implant-grade Titanium Alloy Ti-6Al-4V ELI (conforming to ASTM F136 / ISO 5832-3), Pure Titanium Grade 4 (ASTM F67), PEEK OPTIMA (ISO 10993-1), and Medical Stainless Steel 316L (ASTM F138). Every raw material batch receives full spectrum chemical analysis and mechanical tensile testing prior to machining.
Distributors and medical procurement managers can apply for evaluation sample kits through our Free Sample initiative. Sample sets allow orthopedic surgeons and hospital procurement teams to assess surface finish, thread engagement, instrument ergonomics, and dimensional accuracy prior to placing commercial orders.
Expand your orthopedic portfolio in Moscow with ISO 13485 certified implants, complete biocompatibility test documentation, low MOQ flexibility, and dedicated OEM support.